EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions

Holly C Hunsberger, Priyanka D Pinky, Warren Smith, Vishnu Suppiramaniam, Miranda N Reed iD

Neuronal Signaling · 28.06.2019 · 3 (2)

DOI: 10.1042/ns20180203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuronal Signaling, online erschienen am 18.04.2019. Verfasst von Holly C Hunsberger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH)/New York State Psychiatric Institute (NYSPI), New York, NY 1003…. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is the leading cause of dementia affecting almost 50 million people worldwide. The ε4 allele of Apolipoprotein E (APOE) is the strongest known genetic risk factor for late-onset AD cases, with homozygous APOE4 carriers being approximately 15-times more likely to develop the disease. With 25% of the population being APOE4 carriers, understanding the role of this allele in AD pathogenesis and pathophysiology is crucial. Though the exact mechanism by which ε4 allele increases the risk for AD is unknown, the processes mediated by APOE, including cholesterol transport, synapse formation, modulation of neurite outgrowth, synaptic plasticity, destabilization of microtubules, and β-amyloid clearance, suggest potential therapeutic targets. This review will summarize the impact of APOE on neurons and neuronal signaling, the interactions between APOE and AD pathology, and the association with memory decline. We will then describe current treatments targeting APOE4, complications associated with the current therapies, and suggestions for future areas of research and treatment.

Schlagwörter

Stichwörter der Autor:innen

AlzheimerAmyloidApoeTauTherapeutics

Autor:innen und Institutionen

  • Division of Systems Neuroscience, Research Foundation for Mental Hygiene, Inc. (RFMH)/New York State Psychiatric Institute (NYSPI), New York, NY 10032, U.S.A.
  • Department of Psychiatry, Columbia University, New York, NY 10032, U.S.A.
  • Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn, AL 36849, U.S.A.
  • Center for Neuroscience Initiative, Auburn University, Auburn, AL 36849, U.S.A.

ORCID-Profile: Miranda N Reed

Zitieren

APA

Hunsberger, H. C., Pinky, P. D., Smith, W., Suppiramaniam, V., & Reed, M. N. (2019). The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions. Neuronal Signaling, 3(2). https://doi.org/10.1042/ns20180203

Vancouver

Hunsberger HC, Pinky PD, Smith W, Suppiramaniam V, Reed MN. The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions. Neuronal Signaling. 2019;3(2). doi:10.1042/ns20180203

BibTeX
@article{Hunsberger2019,
  author = {Hunsberger, Holly C and Pinky, Priyanka D and Smith, Warren and Suppiramaniam, Vishnu and Reed, Miranda N},
  title = {The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions},
  journal = {Neuronal Signaling},
  year = {2019},
  volume = {3},
  number = {2},
  doi = {10.1042/ns20180203}
}
Kostenlos starten →